BioNTech SE

Healthcare · Biotechnology

98.60$ -0.5% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

BioNTech SE (BNTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 20,334 million EUR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BNTX
Line item	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	–	–	653	2,270	722	738	798	732	973	1,449	2,319	4,205	9,149	16,495	15,831	20,300	21,155	22,661	23,279	23,988	22,226	22,207	23,006	22,257	22,238	22,401	22,530	21,182	21,638	21,341	21,979	21,096	20,334
Current Assets	172	–	–	449	412	504	501	560	493	621	1,092	1,667	3,536	8,440	15,648	15,072	19,466	20,208	21,269	21,922	21,823	19,214	18,749	19,527	18,274	18,282	18,486	18,804	15,626	15,929	15,831	16,140	15,548	15,291
Cash	-172	–	–	411	-412	285	463	519	452	573	990	1,210	892	914	2,773	1,693	6,164	9,335	13,424	13,875	13,194	14,167	13,496	11,664	8,977	10,377	9,625	9,762	10,185	10,270	10,093	7,672	9,950	9,737
Cash & Short-Term Investments	172	–	–	412	412	476	464	521	453	575	1,008	1,347	892	915	2,773	2,074	6,165	9,335	13,429	14,065	13,194	15,557	15,749	16,549	15,667	17,296	16,709	16,784	14,110	14,037	14,528	14,834	14,652	9,737
Receivables	–	–	–	19	29	9.3	8.9	12	12	10	7.9	166	2,395	7,052	12,290	12,382	12,696	10,383	7,309	7,146	7,593	2,664	2,009	2,161	1,925	287	1,198	1,524	1,027	1,447	700	984	613	245
Inventory	–	–	–	5.8	23	7.3	11	12	9.6	8.6	12	64	147	305	456	503	459	368	295	440	461	449	416	358	345	340	303	283	254	231	226	111	104	101
Property, Plant & Equipment	–	–	–	133	123	123	143	148	145	168	184	326	361	381	442	520	557	664	761	–	–	–	926	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	0.5	0.0	0.0	0.0	3.0	–	–	–	54	–	–	–	58	–	–	–	61	–	366	366	363	369	372	374	381	376	364	358	368	371	373
Intangible Assets	–	–	–	88	299	95	94	84	94	183	169	104	165	164	189	137	216	221	226	145	411	501	666	782	822	862	874	790	1,511	1,487	1,390	1,605	1,548	1,421
Total Liabilities	–	–	–	386	1,062	338	322	304	284	372	522	947	1,685	3,666	6,399	3,937	4,389	4,325	4,294	3,224	1,970	2,319	2,340	2,760	2,289	3,166	3,287	3,119	2,256	3,133	2,864	2,763	2,379	2,584
Current Liabilities	–	–	–	126	427	136	128	138	142	209	268	606	1,311	3,163	5,682	3,482	3,855	3,924	3,958	2,951	1,685	1,819	1,807	2,071	1,606	2,426	2,523	2,523	1,535	1,851	2,223	2,141	1,767	1,948
Short-Term Debt	–	–	–	6.2	0.0	0.9	1.1	5.3	1.1	1.0	1.0	9.1	18	14	22	130	31	32	37	36	41	39	40	28	31	35	37	40	56	52	53	52	57	57
Accounts Payable	–	–	–	42	53	17	22	20	19	36	42	102	106	263	300	160	124	291	297	204	32	229	223	354	299	882	763	427	444	504	400	535	469	646
Long-Term Debt	–	–	–	6.4	36	61	32	0.0	67	70	176	–	237	243	268	172	155	207	237	176	172	167	162	191	205	219	206	215	238	217	192	215	246	259
Shareholders' Equity	-48	–	–	266	267	384	416	493	448	602	928	1,372	2,520	5,483	10,096	11,894	15,911	16,831	18,366	20,056	22,017	19,907	19,867	20,246	19,968	19,072	19,115	19,411	18,927	18,505	18,477	19,216	18,717	17,750
Retained Earnings	–	–	–	-246	-337	-337	-367	-425	-478	-567	-777	-410	719	3,506	7,784	9,883	13,582	14,769	16,554	18,833	21,007	19,145	19,305	19,763	19,448	18,640	18,839	19,098	18,682	18,296	18,267	17,954	17,448	16,602
Shares Outstanding	194	194	227	227	227	229	229	230	223	232	241	245	257	259	260	260	260	259	256	246	245	240	240	241	241	238	245	240	240	242	239	245	253	253

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings